Virpax Pharmaceuticals Engages Destum Partners to Direct Strategic Global Partnering Efforts
CANNANNEW REPORT
BERWYN, Pa.–(BUSINESS WIRE)–#pharma—Virpax® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and viral barrier indications, today announced that the Company has engaged Destum Partners, Inc. to serve as the exclusive advisor for the Company’s partnering and licensing […]
Excerpt only …
READ MORE BELOW
Source : Virpax Pharmaceuticals Engages Destum Partners to Direct Strategic Global Partnering Efforts
reposted by Cannabis News World
You must log in to post a comment.